Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Peptide Process CMCPeptide Process CMC
Not Confirmed
Not Confirmed
28-30 August, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Peptide Process CMCPeptide Process CMC
Industry Trade Show
Not Confirmed
28-30 August, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
11 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/11/3114127/0/en/Neurona-Announces-Publication-in-Neuron-Reporting-Durable-Preclinical-Engraftment-of-Human-Interneuron-Cell-Therapy.html
18 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/18/3101388/0/en/Neurona-Doses-First-Patient-in-Phase-1-2-Trial-of-NRTX-1001-Cell-Therapy-in-Adults-with-Drug-Resistant-Bilateral-Mesial-Temporal-Lobe-Epilepsy-MTLE.html
08 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/08/3057811/0/en/Neurona-Therapeutics-Presents-Positive-Clinical-Data-Update-from-NRTX-1001-Cell-Therapy-Trial-in-Drug-resistant-Epilepsy-at-American-Academy-of-Neurology-Annual-Meeting.html
03 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/03/3055080/0/en/Neurona-Therapeutics-Raises-102-Million-to-Fuel-NRTX-1001-Phase-3-EPIC-Epilepsy-Trial-and-Advance-Regenerative-Cell-Therapy-Pipeline.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029902/0/en/Neurona-Unveils-Phase-3-EPIC-Study-for-NRTX-1001-Cell-Therapy-in-Epilepsy.html
06 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/06/2993169/0/en/Neurona-Therapeutics-Presents-Positive-Clinical-Update-New-Data-from-NRTX-1001-Cell-Therapy-Trial-in-Drug-Resistant-Epilepsy-Announced-at-2024-Annual-Meeting-of-the-American-Epilep.html
ABOUT THIS PAGE